PON1 and ischemic stroke: The clinical significance of this polymorphism resides on the potential association of the gene product with clopidogrel biotransformation (i.e., an alternate pathway mediated by this paraoxonase/arylesterase enzyme) as well as the suggested role of the PON1 192R variant as a risk factor for ischemic stroke and heart diseases [40].